SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Dec 5 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kevin Podsiadlik who wrote (3550)12/18/1999 4:03:00 PM
From: Joe   of 4140
 
Kevin, I understand that this resubmission has a new PMA number. The indication has been changed from "correction of hyperopia" to "reduction of hyperopia". This is very significant change in language.

I believe that what FDA may want in restrictive labeling is already built into the new labeling in this PMA. Further, the two Lehman analysts, both well known MD's in the financial community, are fully aware of the possible restrictive language the ODP may want. While at AAO, I had heard that they did more DD at Sunrise than any financial institution has done in the past.

Joe
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext